Good Morning everyone, its going to be a great week for ISOLIsodiol is one of a kind. It looks too good to be true? You are wrong and are being fooled by the current stock price movement. Their net operational profit is positive, they have 26.4 million $ in the bank and gross profit margin of 54.4%. Financial information: https://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00036046
Here is what Isodiol has accomplished and how it will increase its revenue that, I must say, are already very optimistic.
Remember that bashers are most active on stocks with the most potential.
Current catalysts:
1. Acquisition of Biosynthesis Pharma Group by the end of March (Private company; industry leading producer of industrial hemp, it’s derivatives and pharmaceutical compounds for use in the medicinal, nutraceutical, food, and cosmetic industries, transforming hemp to pharmaceutical grade CBD isolate. BSPG currently has the capability of processing over 1.5 metric tons of hemp biomass daily to extract CBD, terpenes and other cannabinoids, specifically CBG. BSPG has good yet currently non-disclosed revenue.
2. Clinical trial outcomes on their flagship +99% crystalline isolate product (produced by Biosynthesis Pharma Group)
3. University research under non disclosure agreement for their product Immunag (CBD from hops source developped in India)
4. Health Canada license for their wholly owned subsidiary CN Pharma (A pharmaceutical manufacturing company)
5. Letter of intent to import 30kg per month of 99%+ pure pharma-grade CBD to canada from U.K. with Nuuvera (Nuuvera was acquired by Aphria in February) 30kg per month is at least 10 800 000 $ per year.
Isodiol is on a major revenue growth as they expand their presence internationally with the help of their 10 years licensing agreement with Kathy Ireland and Level Brands.
Isodiol has completed strategic financing with the well respected Serruya Private Equity inc.
The Serruya Private Equity Inc. is a global private equity firm focused on transforming companies by collaborating with management to develop and implement strategies which leverage SPE’s existing operational and financial resources.
News you should know:
March 23: Isodiol Signs a letter of inntent to acquire 100% of Kure Corp., a leading specialty vape retailer headquartered in Charlotte, North Carolina, with locations in the United States and annualized unaudited Fiscal 2018 revenue of $8.8m USD.
March 19: Isodiol signs partnership agreement with Kawacatoose First Nation. Under the terms of this agreement, KFN will provide up to 3,000 farmable acres of land to grow hemp, as it becomes available and certain conditions are met by both parties on a cost-plus model.
February 22: Isodiol signs a distribution agreement with Threshold Enterprises for its wholly owned subsidiary Be Tru Wellness (Be Tru). Threshold Enterprises is one of California’s largest manufacturers and distributors of nutritional supplements and other natural products, Threshod offers more than 300 brands and 15,000 products distributed throughout all 50 states, as well as in international markets.
February 15: Isodiol signs a definitive agreement to acquire 100% of Canadian National Pharma group Inc., a pharmaceutical manufacturing company.
February 12: Isodiol announces partnership with Europe's leading MMA promotion, Cage Warriors for their product line Iso-Sport. Cage Warriors prides itself on being the proving ground for MMA’s stars of the future and has been home to some of biggest stars of MMA’s past and present, including Conor McGregor, Michael Bisping, and Dan Hardy.
February 12: Isodiol's Iso-Sport product line commences sales in the European market.
February 8: Isodiol announces the appointment of winter athele brand ambassadors Jazmine Fenlator, Kiley Mckinnon, Kimani Griffin, Faye Gulini and Julia Marino. In January 2018, the World Anti-Doping Agency (WADA) took the position of excepting “Cannabidiol” from the list of cannabinoids contained in their List of Prohibited Substances and Methods (Prohibited List) Publication of the Prohibited List is mandated by the World Anti-Doping Code, to which there are over 660 nation and athletic governing body signatories.
February 5: Isodiol receives received approval from the Brazilian Health Regulatory Agency (Anvisa) approval for Isodiolex for the treatment of epilepsy and parkinson's disease. This product will be placed on the Special Category List for alternative therapies which will enable it to be prescribed by doctors and neurologists.
January 26: Isodiol announces licensing agreement with Livecare Health Canada inc. an organization founded and operated by Doctors dedicated to giving patients access to quality, real-time healthcare, regardless of where they are located.
January 22: Isodiol Announces extension of licensing agreement with Kathy Ireland and Level Brands to 10 years and the territory expanded to worldwide.
January 12: Isodiol signs a binding supply agreement with Namaste Technologies inc. Through this non-exclusive partnership, Isodiol will become a provider of phytoceutical products to Namaste,to be sold through select distribution channels on its e-commerce platform.
January 9: Be tru Organics (wholly owned subsidiary of Isodiol) signs a distribution agreement with UNFI, the largest publicly traded wholesale distributor to the natural, organic and specialty industry in the United States and Canada.
January 2: Isodiol announces non-binding agreement with licensed California marijuana manufacturer for Pot-O-Coffee. The manufacturer has received its adult-use temporary recreational manufacturing license and is now in the final weeks of setting up their facility to produce the Pot-O-Coffee product line.